|
Health & Pharmaceuticals Committee
IPR status in Egypt - January 2000
The committee held meetings
on December 12 and 19 both focusing on the issues of IPR status in
Egypt, an analysis of the draft patent law, social commitments and the
image of the industry. The December 19 meeting featured presentations by
Dr. Samir Khalil, regional director for policy & external affairs
for Merck USA, and Dr. Adel Mahmoud, president of the vaccine
division of Merck USA.
Top
|